US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 78.340
  • -0.340-0.43%
Close Oct 18 16:00 ET
  • 78.340
  • 0.0000.00%
Post 20:01 ET
8.28BMarket Cap-91093P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
46.44%161.28M
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
232.64%71.87M
Operating revenue
46.44%161.28M
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
232.64%71.87M
Cost of revenue
58.51%11.35M
46.64%9.9M
65.07%33.75M
57.66%10.7M
56.05%9.13M
54.04%7.16M
113.98%6.75M
154.42%20.44M
167.35%6.79M
192.35%5.85M
Gross profit
45.60%149.92M
53.38%134.94M
87.34%428.43M
49.80%120.8M
76.74%116.68M
104.20%102.97M
178.42%87.98M
210.41%228.69M
250.98%80.65M
236.75%66.02M
Operating expense
18.32%177.65M
14.32%155.9M
19.40%587.81M
20.96%154.9M
20.34%146.39M
8.53%150.14M
30.80%136.37M
37.00%492.32M
17.50%128.06M
25.50%121.65M
Selling and administrative expenses
20.35%121.57M
14.32%113.09M
14.24%409.86M
10.66%104.72M
19.05%105.21M
0.70%101.01M
31.09%98.92M
31.61%358.78M
18.77%94.63M
25.36%88.38M
Research and development costs
12.83%56.18M
12.65%42.83M
33.72%180.14M
49.94%50.77M
24.87%41.55M
29.21%49.79M
30.92%38.02M
51.63%134.72M
14.95%33.86M
23.09%33.27M
Other operating expenses
83.13%-112K
96.00%-23K
-85.70%-2.2M
-36.01%-593K
---363K
-31.49%-664K
-138.59%-575K
43.58%-1.18M
-181.29%-436K
----
Operating profit
41.24%-27.72M
56.70%-20.95M
39.54%-159.38M
28.08%-34.1M
46.59%-29.71M
46.34%-47.18M
33.40%-48.39M
7.72%-263.63M
44.87%-47.41M
28.06%-55.63M
Net non-operating interest income expense
155.19%11.56M
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
439.95%2.12M
Non-operating interest income
155.19%11.56M
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
439.95%2.12M
Other net income (expense)
Income before tax
62.10%-16.16M
66.20%-14.89M
45.74%-139.04M
36.10%-28.13M
54.74%-24.22M
50.75%-42.65M
38.93%-44.04M
9.81%-256.25M
48.65%-44.03M
30.45%-53.51M
Income tax
-57.78%57K
3,490.00%359K
10,500.00%636K
448K
4,200.00%43K
135K
100.00%10K
0.00%6K
0
104.35%1K
Net income
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
Net income continuous Operations
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
Minority interest income
Net income attributable to the parent company
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
Basic earnings per share
64.44%-0.16
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
40.00%-0.57
Diluted earnings per share
64.44%-0.16
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
40.00%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 46.44%161.28M52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M232.64%71.87M
Operating revenue 46.44%161.28M52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M232.64%71.87M
Cost of revenue 58.51%11.35M46.64%9.9M65.07%33.75M57.66%10.7M56.05%9.13M54.04%7.16M113.98%6.75M154.42%20.44M167.35%6.79M192.35%5.85M
Gross profit 45.60%149.92M53.38%134.94M87.34%428.43M49.80%120.8M76.74%116.68M104.20%102.97M178.42%87.98M210.41%228.69M250.98%80.65M236.75%66.02M
Operating expense 18.32%177.65M14.32%155.9M19.40%587.81M20.96%154.9M20.34%146.39M8.53%150.14M30.80%136.37M37.00%492.32M17.50%128.06M25.50%121.65M
Selling and administrative expenses 20.35%121.57M14.32%113.09M14.24%409.86M10.66%104.72M19.05%105.21M0.70%101.01M31.09%98.92M31.61%358.78M18.77%94.63M25.36%88.38M
Research and development costs 12.83%56.18M12.65%42.83M33.72%180.14M49.94%50.77M24.87%41.55M29.21%49.79M30.92%38.02M51.63%134.72M14.95%33.86M23.09%33.27M
Other operating expenses 83.13%-112K96.00%-23K-85.70%-2.2M-36.01%-593K---363K-31.49%-664K-138.59%-575K43.58%-1.18M-181.29%-436K----
Operating profit 41.24%-27.72M56.70%-20.95M39.54%-159.38M28.08%-34.1M46.59%-29.71M46.34%-47.18M33.40%-48.39M7.72%-263.63M44.87%-47.41M28.06%-55.63M
Net non-operating interest income expense 155.19%11.56M39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M439.95%2.12M
Non-operating interest income 155.19%11.56M39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M439.95%2.12M
Other net income (expense)
Income before tax 62.10%-16.16M66.20%-14.89M45.74%-139.04M36.10%-28.13M54.74%-24.22M50.75%-42.65M38.93%-44.04M9.81%-256.25M48.65%-44.03M30.45%-53.51M
Income tax -57.78%57K3,490.00%359K10,500.00%636K448K4,200.00%43K135K100.00%10K0.00%6K0104.35%1K
Net income 62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M
Net income continuous Operations 62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M
Minority interest income
Net income attributable to the parent company 62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M
Basic earnings per share 64.44%-0.1665.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.4540.00%-0.57
Diluted earnings per share 64.44%-0.1665.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.4540.00%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data